This article had 2 aims: (a) to comprehensively review and synthesize the literature on predictors of health service utilization in survivors of traumatic events and posttraumatic stress disorder (PTSD) patients and (b) to discuss methodological issues in examining service utilization in this population. PsycINFO was searched for relevant articles published through April 2004. Included studies had to primarily sample trauma survivors or PTSD patients and statistically explore health service use determinants. Although some findings conflicted across studies, increased mental health service use was generally related to being female, having a previous trauma history, and having a PTSD diagnosis. Increased medical service use was found among those with a PTSD diagnosis. Methodological recommendations are made for future health service use studies.
Few studies have conducted symptom comparisons across different trauma-exposed populations. Evidence linking different types of trauma to variations in clinical presentation would have potential implications for the assessment and treatment of trauma-related psychopathology. The current study evaluated whether military veterans (n = 187) and civilian crime victims (n = 47) diagnosed with posttraumatic stress disorder differ in their self-reported posttraumatic symptoms as measured by the Trauma Symptom Inventory. A multivariate profile analysis revealed that military-related trauma is associated with more severe posttraumatic symptoms than criminal victimization and suggested that these 2 types of trauma have statistically distinct symptom profiles. Some potential implications of these findings and considerations for future research are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.